Clinical Trials
6 trialsNCT02555748 2026-03-31
SUP-R
Institut Claudius Regaud
Phase 4 Completed
NCT02691793 2022-06-15
Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors
Samsung Medical Center
Phase 4 Completed
NCT01525550 2019-07-30
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Pfizer
Phase 4 Completed
NCT01402089 2016-02-02
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00793871 2015-11-20
GIST
Pfizer
Phase 4 Completed
NCT00706706 2013-01-18
MRCC RCC
Pfizer
Phase 4 Completed